Why The $300 Level Is So Important For The Biotech ETF

biotech-dna
From Taki Tsaklanos: Biotechnology stocks are breaking out. They have been consolidating for nearly 20 months. Investors lost interest...and that is exactly what smart investors, in general, want to see in order to buy a market.
NASDAQ:IBB March 3, 2017 6:13am

Pharma ETFs In Focus As Washington Debates Prescription Drug Pricing

white-pills
With all of the talk from Capitol Hill in regards to prescription pill prices and proposed healthcare reform, today we hone in on the Pharmaceutical segment within the greater Healthcare industry sector in ETF land.
NYSE:PJP March 2, 2017 12:00pm

Healthcare Sector On The Verge Of A Major Breakout — Or Breakdown

pills healthcare
From Taki Tsaklanos: The healthcare stock market sector is the outperforming sector in the S&P 500 in February 2017. Though this is an interesting insight for investors, the more important observation is the chart setup of the health sector (which is discussed in more detail in this article).
NYSE:XLV February 26, 2017 6:41am

Analyst: Big Opportunities Coming In Medical Device Space

Medical Device
From The Gold Report: The stage has been set for high levels of uncertainty, and with uncertainty comes opportunities in commodities, posits Lior Gantz, editor of Wealth Research Group, who also sees opportunities in disruptive technologies in the medical arena.
NYSE:XHE February 24, 2017 7:45am

Healthcare Is Bouncing Back, And Medical Devices Are Leading The Way

Medical Device
From Taki Tsaklanos: The health care stock market sector is back in shape. The XLV ETF representing the healthcare sector was up 0.14 percent for the day and 2.2 percent for the week.
NYSE:IHI February 18, 2017 8:43am

A Major Recovery Is Brewing In The Biotech & Healthcare Space

white-pills
From Taki Tsaklanos: Biotechnology was once the darling of stock market investors. Not so anymore, since the summer of 2015 the sector collapsed from 400 points to 250 points in the IBB ETF.
NASDAQ:IBB February 17, 2017 6:33am

The Healthcare Sector’s Performance Has Zero Correlation With Earnings Estimates

Medical Device
From Eric Bush: Equity returns and earnings estimates should presumably be related. It makes intuitive sense that if earnings estimates are increasing for a sector than equity prices for that sector should trend upwards as well.
NYSE:XLV February 15, 2017 6:39am

Health Care ETFs Are Soaring Amid Big Inflows, Muted Trump Worries

biotech-white-pills
Even though rhetoric out of Trump’s White House lately has sounded bearish for prescription pill prices, we have seen bullish momentum in the largest Health Care sector fund in the U.S. listed landscape, XLV (SPDR Health Care Select Sector, Expense Ratio 0.15%), as well as substantial inflows this week.
NYSE:XLV February 9, 2017 12:51pm

These Health Care Stocks Are The Best Options In A Weak Sector

biotech-white-pills
From Taki Tsaklanos: The health care stock market sector evolved from a leader to a laggard in the last 18 months. Health care stocks have a divergence right now: most stocks are underperformers, a minority show strength and are preparing a breakout, and there is a handful of stocks showing great leadership.
NYSE:BSX February 6, 2017 6:50am

Merck Issues Weak Forecast As Q4 Revenue Falls Short

merck-logo
From StockNews.com: Merck & Co., Inc. (NYSE:MRK) early Thursday posted mixed fourth quarter earnings and provided a tepid outlook, as it suffers through multiple patent expirations of key medications.
NYSE:MRK February 2, 2017 7:26am

Trump’s War On Drug Prices Not The Only Concern For Pharma Companies

Image of multicolor pills in blister pack
From Brad Hoppmann: The news out of Washington keeps flooding out, and specifically news that’s being made straight from the Oval Office.
NYSE:PJP February 1, 2017 7:26am

Pfizer Provides Tepid Outlook As Q4 Results Miss Expectations

pfizer-pfe-logo
From StockNews.com: Pfizer Inc. (NYSE:PFE) early Tuesday posted disappointing fourth quarter results and offered a tepid outlook, amid weakening demand for some of its key drugs.
NYSE:PFE January 31, 2017 7:14am

AbbVie Issues In-Line Outlook Following Mixed Q4 Earnings

abbvie-logo
From StockNews.com: AbbVie Inc (NYSE:ABBV) early Friday posted mixed fourth quarter earnings results and issued a 2017 forecast that was in-line with Wall Street expectations.
NYSE:ABBV January 27, 2017 8:19am

Bristol-Myers Slashes Outlook As Q4 Profit Misses The Mark

BristolMyersSquibb-Co-logo
From StockNews.com: Bristol-Myers Squibb Co (NYSE:BMY) early Thursday posted mixed fourth quarter earnins reuslts and lowered its 2017 outlook, amid fears of regulators capping drug prices.
NYSE:BMY January 26, 2017 8:09am

Recommended for You

Explore More from ETFDailyNews.com

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again!

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories